Zynex, Inc. Share Price

Equities

ZYXI

US98986M1036

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
11.21 USD +2.47% Intraday chart for Zynex, Inc. -1.49% +2.94%
Sales 2024 * 227M 18.21B Sales 2025 * 290M 23.24B Capitalization 358M 28.65B
Net income 2024 * 17M 1.36B Net income 2025 * 32M 2.56B EV / Sales 2024 * 1.43 x
Net cash position 2024 * 33.11M 2.65B Net cash position 2025 * 11.06M 885M EV / Sales 2025 * 1.19 x
P/E ratio 2024 *
23.2 x
P/E ratio 2025 *
12 x
Employees 1,100
Yield 2024 *
-
Yield 2025 *
-
Free-Float 38.54%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.47%
1 week-1.49%
Current month-9.38%
1 month-9.23%
3 months-1.58%
6 months+56.78%
Current year+2.94%
More quotes
1 week
10.89
Extreme 10.89
11.53
1 month
10.89
Extreme 10.89
12.84
Current year
9.80
Extreme 9.8
13.77
1 year
6.88
Extreme 6.88
14.75
3 years
4.97
Extreme 4.97
17.25
5 years
4.95
Extreme 4.9455
27.02
10 years
0.06
Extreme 0.0552
27.02
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 31/12/95
Director of Finance/CFO 51 04/06/17
Chief Operating Officer 38 31/01/18
Members of the board TitleAgeSince
Director/Board Member 74 09/01/18
Chief Executive Officer 65 31/12/95
Director/Board Member 66 09/01/18
More insiders
Date Price Change Volume
26/04/24 11.21 +2.47% 113,340
25/04/24 10.94 -2.58% 103,051
24/04/24 11.23 -0.27% 127,688
23/04/24 11.26 +1.08% 180,593
22/04/24 11.14 -2.11% 155,913

Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm

More quotes
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
11.21 USD
Average target price
18.98 USD
Spread / Average Target
+69.31%
Consensus